Compare ALVO & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | SLI |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | Luxembourg | Canada |
| Employees | 1032 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 2011 |
| Metric | ALVO | SLI |
|---|---|---|
| Price | $3.62 | $3.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $8.00 | $5.25 |
| AVG Volume (30 Days) | 605.3K | ★ 1.7M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $37.82 | N/A |
| Revenue Next Year | $25.80 | N/A |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $1.08 |
| 52 Week High | $11.85 | $6.40 |
| Indicator | ALVO | SLI |
|---|---|---|
| Relative Strength Index (RSI) | 47.47 | 37.02 |
| Support Level | $3.03 | $2.91 |
| Resistance Level | $4.17 | $4.54 |
| Average True Range (ATR) | 0.19 | 0.26 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 70.00 | 21.51 |
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, and Bristol Dry Lake Project.